Globalisation on pause? How scaleups can navigate today's uncertainty9:30 am - 10:30 am
Dolphin Homes secures £2m follow-on funding
Portsmouth headquartered specialist care provider Dolphin Homes has secured a further £2m investment from BGF, to support the building of two further care homes in Hampshire.
Founded in 1988 and based across West Sussex, Hampshire and Surrey, Dolphin Homes provides high-quality care and support for young adults with learning difficulties, challenging behaviour, physical disabilities and other complex health needs. The business is focused on a high quality of care, supporting residents to live independent lives as active and valued members of the community.
BGF invested £3.25m into Dolphin Homes in 2017 to fund the roll out of additional homes, as well as further support for Dolphin’s existing homes. The £2m follow-on investment will be used to build two further care homes in Hampshire, expanding the business’s potential to provide high-quality care to more residents on the South Coast.
Nick Heather, CEO of Dolphin Homes, said: “The foundation of our business is to provide the best quality care and support for residents, supporting them to live as independently as possible and providing them with a relaxed and comfortable environment to do so. We’re proud of the business we’ve built and with BGF’s continued funding and support, we’re looking forward to reaching more young adults that need our services.”
Greg Norman, an investor at BGF, said: “Nick and the team have great ambitions for the growth of the business, as well as an unwavering commitment to providing high-quality care for the residents they support. We’re pleased to continue as a long-term investment partner, supporting the team and providing funding for this next stage of growth.”
Business funding news
OSL receives £3.5 million follow-on investment as impressive growth continues
BGF has invested a further £3.5 million into leading counter-drone technologies business Operational Solutions Limited (OSL), taking its total investment…
ViaNautis raises £20 million Series A financing to drive the next generation of genetic nanomedicines
ViaNautis Bio, a ground-breaking nanomedicine company at the forefront of genetic therapies, has completed its Series A funding round, raising…